Royalty Pharma (RPRX) Dividends Paid - Common (2019 - 2026)
Royalty Pharma (RPRX) posted Dividends Paid - Common of $39.9 million for Q1 2026, down 2.15% sequentially from $40.8 million in Q4 2025, and down 25.92% YoY from $53.8 million in Q1 2025.
Royalty Pharma (RPRX) Dividends Paid - Common (2019 - 2026) Analysis & Trends
Royalty Pharma has reported Dividends Paid - Common for 8 years, with the latest figure at $39.9 million in Q1 2026.
- Quarterly Dividends Paid - Common fell 25.92% year-over-year to $39.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.5 million (up 4.45% YoY) and the FY2025 annual result came in at $167.5 million, up 33.81% from the prior year.
- Dividends Paid - Common fell to $39.9 million in Q1 2026 per RPRX's latest filing, from $40.8 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $53.8 million in Q1 2025 and troughed at $24.5 million in Q4 2023.
- A 5-year average of $35.1 million and a median of $33.4 million in 2023 frame the typical range for Dividends Paid - Common.
- The widest YoY moves for Dividends Paid - Common: up 114.4% in 2022, down 72.55% in 2022.
- Over 5 years, Dividends Paid - Common stood at $33.2 million in 2022, then retreated by 26.13% to $24.5 million in 2023, then rose by 28.42% to $31.4 million in 2024, then gained by 29.6% to $40.8 million in 2025, then slipped by 2.15% to $39.9 million in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $39.9 million, $40.8 million, and $34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.60 Mn |
| Jun 30, 2026 | 34.60 Mn |
| Mar 31, 2026 | 39.88 Mn |
| Mar 31, 2026 | 39.88 Mn |
| Dec 31, 2025 | 40.76 Mn |
| Dec 31, 2025 | 40.76 Mn |
| Sep 30, 2025 | 34.28 Mn |
| Sep 30, 2025 | 34.28 Mn |
| Jun 30, 2025 | 38.61 Mn |
| Jun 30, 2025 | 38.61 Mn |
| Mar 31, 2025 | 53.83 Mn |
| Mar 31, 2025 | 53.83 Mn |
| Dec 31, 2024 | 31.45 Mn |
| Dec 31, 2024 | 31.45 Mn |
| Sep 30, 2024 | 31.02 Mn |
| Sep 30, 2024 | 31.02 Mn |
| Jun 30, 2024 | 30.68 Mn |
| Jun 30, 2024 | 30.68 Mn |
| Mar 31, 2024 | 32.01 Mn |
| Mar 31, 2024 | 32.01 Mn |